June 9, 2021 -- Nonprofit biotechnology firm Essent Biologics has launched human mesenchymal stem cells (hMSCs) for applications in regenerative medicine and biopharmaceutical and cell therapy research.
The stem cells are recovered, expanded, and cryopreserved without the use of antibiotics or animal products. To ensure potency, each vial contains more than 1 million cells at thaw and a passage level of P0 or P1.
Full donor information and a source biopsy are also available with each stem cell order.